{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:30:12Z","timestamp":1794475812525,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcpo.2026.100773","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:28:22Z","timestamp":1783204102000},"page":"100773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Science or spin? A descriptive analysis of how oncology trials are presented in three short form digital media outlets"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3252-169X","authenticated-orcid":false,"given":"Callie","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9661-9550","authenticated-orcid":false,"given":"Preetam","family":"Cholli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-3978","authenticated-orcid":false,"given":"Alyson","family":"Haslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-8221","authenticated-orcid":false,"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcpo.2026.100773_bib1","article-title":"Global trends in oncology research: A mixed-methods study of publications and clinical trials from 2010 to 2019","volume":"6","author":"Akiki","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.jcpo.2026.100773_bib2","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1200\/JOP.2011.000493","article-title":"Visit Duration for Outpatient Physician Office Visits Among Patients With Cancer","volume":"8","author":"Guy","year":"2012","journal-title":"JOP"},{"key":"10.1016\/j.jcpo.2026.100773_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1200\/CCI.20.00084","article-title":"Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System","volume":"4","author":"La","year":"2020","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.jcpo.2026.100773_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2021.04.007","article-title":"Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer","volume":"156","author":"Waterhouse","year":"2021","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.jcpo.2026.100773_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1634\/theoncologist.2015-0478","article-title":"Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma","volume":"21","author":"Sanoff","year":"2016","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.jcpo.2026.100773_bib6","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1093\/annonc\/mdt397","article-title":"Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials","volume":"24","author":"Templeton","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jcpo.2026.100773_bib7","unstructured":"OncLive YouTube Channel. \u3008https:\/\/www.youtube.com\/user\/onclivetv\u3009. Accessed June 26, 2025."},{"key":"10.1016\/j.jcpo.2026.100773_bib8","unstructured":"VJOncology YouTube Channel. \u3008https:\/\/www.youtube.com\/\u3009@VJOncology. Accessed June 26, 2025."},{"issue":"10","key":"10.1016\/j.jcpo.2026.100773_bib9","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jamaoncol.2018.3738","article-title":"Financial Conflicts of Interest Among Oncologist Authors of Reports of Clinical Drug Trials","volume":"4","author":"Wayant","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jcpo.2026.100773_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/OP.24.00032","article-title":"Financial Conflicts of Interest: Payment at the Expense of Patients?","volume":"20","author":"Nina Niu Sanford","year":"2024","journal-title":"JCO Oncol. Pract."},{"issue":"11","key":"10.1016\/j.jcpo.2026.100773_bib11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.6004\/jnccn.2021.7016","article-title":"Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?","volume":"19","author":"Sharma","year":"2021","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.jcpo.2026.100773_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2023.100411","article-title":"Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology","volume":"36","author":"Sharma","year":"2023","journal-title":"J. Cancer Policy"},{"key":"10.1016\/j.jcpo.2026.100773_bib13","unstructured":"Open Payments. \u3008https:\/\/openpaymentsdata.cms.gov\/\u3009. Last accessed June 26, 2025."},{"key":"10.1016\/j.jcpo.2026.100773_bib14","unstructured":"The Drug Development Process \u2013 Step 3: Clinical Research. \u3008https:\/\/www.fda.gov\/patients\/drug-development-process\/step-3-clinical-research\u3009. Last accessed June 26, 2025."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100773_bib15","first-page":"1121","article-title":"Clinical endpoints in oncology - a primer","volume":"11","author":"Delgado","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"8","key":"10.1016\/j.jcpo.2026.100773_bib16","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jamainternmed.2015.2829","article-title":"The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses","volume":"175","author":"Prasad","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jcpo.2026.100773_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejca.2018.11.012","article-title":"A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology","volume":"106","author":"Haslam","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.jcpo.2026.100773_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.2009.25.8608","article-title":"Generalizing the results of cancer clinical trials","volume":"28","author":"Meyer","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcpo.2026.100773_bib19","first-page":"539","article-title":"Five Years of Cancer Drug Approvals: Innovation, Efficacy, and Costs","volume":"1","author":"Mailankody","year":"2015"},{"issue":"3","key":"10.1016\/j.jcpo.2026.100773_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1634\/theoncologist.2015-0516","article-title":"Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting","volume":"21","author":"Massey","year":"2016","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.jcpo.2026.100773_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cct.2012.05.011","article-title":"The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials","volume":"33","author":"Lerner","year":"2012","journal-title":"Contemp. Clin. Trials"},{"issue":"12","key":"10.1016\/j.jcpo.2026.100773_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1001\/jamaoncol.2016.2710","article-title":"Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors","volume":"2","author":"Mitchell","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jcpo.2026.100773_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12910-015-0063-3","article-title":"The importance of values in evidence-based medicine","volume":"16","author":"Kelly","year":"2015","journal-title":"BMC Med. Ethics"},{"issue":"9","key":"10.1016\/j.jcpo.2026.100773_bib24","first-page":"607","article-title":"The utility of cost discussions between patients with cancer and oncologists","volume":"21","author":"Zafar","year":"2015","journal-title":"Am. J. Manag. Care"},{"issue":"2","key":"10.1016\/j.jcpo.2026.100773_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jval.2016.11.008","article-title":"Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient Values","volume":"20","author":"Armstrong","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.jcpo.2026.100773_bib26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/AMEP.S492302","article-title":"Exploring Differences in Clinical Decisions Between Medical Students and Expert Clinicians","volume":"15","author":"Rojas","year":"2024","journal-title":"Adv. Med. Educ. Pract."},{"key":"10.1016\/j.jcpo.2026.100773_bib27","first-page":"509","volume":"2016","author":"Islam","year":"2016"},{"issue":"2","key":"10.1016\/j.jcpo.2026.100773_bib28","first-page":"71","article-title":"Evidence-based medicine and clinical expertise","volume":"8","author":"Tonelli","year":"2006","journal-title":"Virtual Mentor."},{"issue":"9","key":"10.1016\/j.jcpo.2026.100773_bib29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/jama.298.9.1010","article-title":"Medicine residents' understanding of the biostatistics and results in the medical literature","volume":"298","author":"Windish","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcpo.2026.100773_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/feduc.2022.1036627","article-title":"Critical appraisal of medical literature in undergraduate and postgraduate medical students","volume":"7","author":"Mlika","year":"2022","journal-title":"Front. Educ."},{"issue":"4","key":"10.1016\/j.jcpo.2026.100773_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4300\/JGME-D-10-00172.1","article-title":"Senior internal medicine residents' confidence with essential topics in evidence-based medicine taught during internship","volume":"3","author":"Keddis","year":"2011","journal-title":"J. Grad. Med. Educ."},{"key":"#cr-split#-10.1016\/j.jcpo.2026.100773_bib32.1","unstructured":"Northwestern Health Sciences University and Regents of the University of Minnesota. Articles about treatment worksheet [Internet]. c2013 [revised 2013 Sept 19"},{"key":"#cr-split#-10.1016\/j.jcpo.2026.100773_bib32.2","unstructured":"cited 2026 Mar 14]. Available from: \u3008https:\/\/www.nwhealth.edu\/wp-content\/uploads\/2019\/05\/articles-about-treatment-worksheet.pdf\u3009."},{"key":"10.1016\/j.jcpo.2026.100773_bib33","unstructured":"JBI. Critical appraisal tools [Internet]. [cited 2026 Mar 14]. Available from: \u3008https:\/\/jbi.global\/critical-appraisal-tools\u3009."},{"key":"10.1016\/j.jcpo.2026.100773_bib34","unstructured":"Critical Appraisal Skills Programme. CASP randomised controlled trial checklist. [Internet]. 2023. [cited 2026 Mar 14]. Available from: \u3008https:\/\/casp-uk.net\/casp-tools-checklists\/randomised-controlled-trial-rct-checklist\/\u3009."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213538326000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:06:32Z","timestamp":1794474392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213538326000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S2213538326000743"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100773","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Science or spin? A descriptive analysis of how oncology trials are presented in three short form digital media outlets","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100773"}}